Cellular mechanisms underlying steroid refractory asthma

Philip Hansbro (Callaghan, Australia)

Source: ERS Lung Science Conference 2019
Number: 12
Disease area: Airway diseases

PDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Philip Hansbro (Callaghan, Australia). Cellular mechanisms underlying steroid refractory asthma. ERS Lung Science Conference 2019

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Cellular mechanisms underlying steroid-resistant asthma
Source: Eur Respir Rev, 28 (153) 190096; 10.1183/16000617.0096-2019
Year: 2019



Mechanisms and physiology of asthma
Source: ERS Satellites 2021
Year: 2021

Involvement of epigenetic factor in regulation of steroid resistant bronchial asthma patients
Source: International Congress 2018 – Identification of therapeutic targets for asthma
Year: 2018

Epigenetic mechanisms of allergies and asthma
Source: International Congress 2016 – New insights into the genetics of asthma
Year: 2016


The interplay of LXA4 and glucocorticoid receptor-based mechanisms in airway inflammation of childhood asthma
Source: Annual Congress 2011 - Asthma: basic science and clinical studies
Year: 2011

Still unclear: patients understanding of the role of their inhaled corticosteroid
Source: Eur Respir J 2002; 20: Suppl. 38, 623s
Year: 2002

Some pathogenetic mechanisms of inflammatory processes in smoking patients with COPD
Source: Annual Congress 2007 - Smoking and the lung
Year: 2007


Epigenetic mechanisms and the relationship to childhood asthma
Source: Eur Respir J 2010; 36: 950-961
Year: 2010



Mechanisms of COPD exacerbations - molecular perspectives and pathophysiology
Source: ERS Satellites 2021
Year: 2021

Lymphocyte apoptosis in atopic bronchial asthma: the mechanisms, role in pathogenesis and therapy
Source: Eur Respir J 2004; 24: Suppl. 48, 38s
Year: 2004

The pharmacogenetic aspects of corticosteroid metabolism in patients with severe asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 523s
Year: 2006

The glucocorticoid nuclear action peculiarities in the steroid-resistant patients with severe bronchial asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 32s
Year: 2003

Genes, mechanisms and new therapies for asthma
Source: Lung Science Conference 2010 - Biology of gene-environment interactions in the lung
Year: 2010



Possible mechanisms of worsening bronchial asthma coexisting with thyroid gland pathology
Source: Annual Congress 2013 –Asthma: new mechanisms and markers
Year: 2013


Spontaneous, Fas- and glucocorticoid (GC)-mediated lymphocyte apoptosis in atopic bronchial asthma(ABA): mechanisms, role in pathogenesis and therapy
Source: Eur Respir J 2003; 22: Suppl. 45, 290s
Year: 2003

To the molecular genetic mechanisms of the COPD pathogenesis
Source: International Congress 2018 – Functional genomics and COPD: new challenges
Year: 2018

The mechanisms of anti-inflammatory action of bronchodilators
Source: Annual Congress 2013 –COPD: experimental biology
Year: 2013

New phenotyping of corticosteroid-resistant asthma based on molecular mechanisms
Source: Annual Congress 2005 - Genetic polymorphisms and molecular mechanisms in asthma pathophysiology
Year: 2005


T-cell susceptibility to glucocorticoid (GC)-induced apoptosis: the role in asthma pathogenesis and therapy
Source: Eur Respir J 2006; 28: Suppl. 50, 227s
Year: 2006